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Abstract
Background: The human influenza viruses undergo rapid evolution (especially in hemagglutinin (HA), a glycoprotein
on the surface of the virus), which enables the virus population to constantly evade the human immune system.
Therefore, the vaccine has to be updated every year to stay effective. There is a need to characterize the evolution of
influenza viruses for better selection of vaccine candidates and the prediction of pandemic strains. Studies have shown
that the influenza hemagglutinin evolution is driven by the simultaneous mutations at antigenic sites. Here, we analyze
simultaneous or co-occurring mutations in the HA protein of human influenza A/H3N2, A/H1N1 and B viruses to
predict potential mutations, characterizing the antigenic evolution.
Methods: We obtain the rules of mutation co-occurrence using association rule mining after extracting HA1
sequences and detect co-mutation sites under strong selective pressure. Then we predict the potential drifts with
specific mutations of the viruses based on the rules and compare the results with the “observed” mutations in
different years.
Results: The sites under frequent mutations are in antigenic regions (epitopes) or receptor binding sites.
Conclusions: Our study demonstrates the co-occurring site mutations obtained by rule mining can capture the
evolution of influenza viruses, and confirms that cooperative interactions among sites of HA1 protein drive the
influenza antigenic evolution.
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Background
Influenza has been a major and persistent threat to pub-
lic health for centuries, causing millions of deaths and
huge economic loss worldwide every year. Among the
three types of human influenza viruses, denoted as A, B
and C, influenza A viruses are the most virulent due to
their high mutation rate, frequent genetic reassortment
and short generation time, which have caused several
pandemics in recent history [1, 2]. The pandemics in-
clude 1918 Spanish flu (A/H1N1) [3], 1957 (A/H2N2)
Asia flu [4], 1968 Hongkong flu (A/H3N2) [5] and 2009
swine flu (A/H1N1) [6]. Influenza B viruses, evolving
into B/Yamagata and B/Victoria lineages and frequently
exchanging their segments, have been co-circulating since
2001 and cause an observably part of infections [7, 8].
Under the surveillance and monitoring by WHO (World
Health Organization), influenza activity was detected to be
associated with the co-circulation of influenza A/H1N1
pdm09, A/H3N2 and B viruses [9]. Therefore, to predict
and prevent potential pandemics in the future, it is
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important to analyze and compare the evolutionary
patterns of the three types of viruses.
Haemagglutinin (HA) is a surface glycoprotein of in-
fluenza virus responsible for binding specificity and
initiating the viral entry. It can be cleaved into two
polypeptides: HA1 and HA2 subunits, which are cova-
lently linked by a disulfide bond [10]. HA1 contains
the sialic acid receptor binding sites, and is considered
as one of the main targets of immune system to detect
influenza virus, as well as the primary protein component
of vaccine [10–12]. Under rapid mutations (substitution
rate estimated to be 5.7 × 10− 3per site per year [13]),
the HA1 domain accumulates mutations causing viral
antigenic drift and thus preclude effective vaccination
with existing vaccines [14]. Identifying the evolutionary
trajectories and predicting future mutations would be
very helpful for recommending efficient influenza vac-
cines before a potential variant causes an influenza out-
break. Therefore, many studies have attempted to track
and predict the antigenic evolutionary dynamics of the
HA protein. Phylogenetic tree analysis is a traditional
technique in this field. Studies based on phylogenetic
tree analysis revealed that a single predominant trunk
lineage persists through time while side branches persist
for 1 ∼ 5 years before going extinct [15–17], indicating a
strong selection preference in the evolutionary path. Many
methods have been proposed to identify single mutation
sites under positive selection and thereby understand the
antigenic evolution of HA [18–20]. Statistical analysis and
machine learning approaches have also been applied to
reveal more information about the mutational dynamics
in the viral sequences. The pioneering work by Smith et
al. [21] characterized the antigenic evolution of HA1 (A/
H3N2) based on the Hemagglutination-inhibition (HI) as-
says, and mapped the antigenic evolution (phenotype) to
the phylogenetic tree based on HA1 sequences (genotype)
using a maximum-likelihood (ML) approach. Smith’s
method was enhanced by Bedford et al. in [22] by simul-
taneously characterizing antigenic and genetic evolution
using a diffusion model over a shared virus phylogeny.
Plotkin et al. [23] adopted a clustering technique to inves-
tigate the spatio-temporal evolution of antigenic clusters.
A Bayesian approach was applied in [24] to predict the
antigenic relationships of H3N2 viruses, which were used
to identify the antigenic clusters and infer the dynamics of
antigenic evolution. The relationship between the anti-
genic distances based on sequences and those calculated
from HI titer data was further discussed in [25], where an
online tool named “nextflu” was provided for real-time
tracking. Although those studies have obtained insightful
results, most of them focus on the clusters of antigenic
mutations. Currently very few studies work on the interac-
tions among site mutations in the HA proteins and their
impact on the direction of antigenic evolution.
It has been observed that simultaneous multi-site muta-
tions (or co-occurring mutations) at antigenic sites could
accumulatively enhance the antigenic drift [26, 27]. Co-
occurring mutations can be categorized into stochastic
co-evolution, functional co-evolution and interaction
evolution [28]. One site on a protein may compensate
for another during evolution; thus mutations on these
sites are under positive selection pressure and occur
simultaneously (i.e. co-occurring mutations). The identifi-
cation of co-occurring mutations can help uncover pos-
sible interactions among them and thereby improve our
understanding of the mutational dynamics of proteins.
Mutual information has been used to estimate the cor-
relations between two site mutations [29, 30]. The cor-
relation network (named site transition network or STN
in [29]) based on mutual information can be used to pre-
dict the future mutations of sites in HA protein. Results in
[29] showed that the STN can predict site mutations with
70% accuracy. However, mutual information is limited to
pairwise relationships. How multiple sites interact with
each other is yet to be discovered.
Here, we propose a method based on association
rule mining [31] to identify co-occurring patterns of
multiple-site mutations. Association rule mining has
been shown as a promising technique in bioinformatic
analysis [32, 33]. Our approach offers a flexible way to
discover the interactions of multiple site mutations,
not limited to pairwise interactions as in [29]. Besides,
the rules of co-occurring mutations provide interpretabil-
ity, making it easy for human to understand the under-
lying process of antigenic evolution. Furthermore, our
rules can also be used to predict potential mutations in
the sites of HA1.
Results
Rules of co-occurring mutations
First we look at all the available sequences of human in-
fluenza H1N1, H3N2 and B viruses in the Influenza
Virus Resource database of NCBI [34] from 1918 to
2015. To avoid “gaps” in the data from some years, we
used the sequences from 1976 to 2015 for H1N1, from
1968 to 2015 for H3N2, and from 1975 to 2015 for flu-B
Table 1 Overview of extracted rules
Dataset Number of Extracted Rules Support Confidence
A/H3N2 (1968–2015) 2266 1000 0.6
A/H1N1 (1975–2015) 27704 2000 0.8
A/H1N1 (pdm) 710 5500 0.8
A/H1N1 (aft) 181 2000 0.8
B (1976–2015) 24465 5000 0.8
B/Yamagata 1110 1500 0.8
B/Victoria 69 1500 0.8
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virus (see Methods). Using association rule mining, we
discovered 24,465 rules for B virus with support and
confidence larger than 5000 and 0.8 respectively. For
A/H1N1 and A/H3N2 viruses, however, the support
and confidence of rules are lower. Therefore, we reduced
the threshold and obtained 27,704 rules for A/H1N1
with support and confidence larger than 2000 and 0.8
respectively. And for A/H3N2, there are 2266 rules
with support and confidence larger than 1000 and 0.6
respectively. Details can be found in Table 1.
To compare the patterns of co-occurring mutations in
different types of influenza viruses, we visualize the rules as
follows. For the rules with the form X1,…,Xn= > Y , we plot
a network to represent the rules, by treating X1,…,Xn as
input nodes and Y as the target node. The networks of site
mutations in the HA1 protein of influenza B, A/H1N1 and
A/H3N2 viruses are shown in Additional file 1: Figure S1,
Additional file 2: Figure S2 and Additional file 3: Figure
S3. We can see that the “interactions” (i.e. the associa-
tions of items in the rules) are much denser in flu B
virus than those in A/H1N1 and A/H3N2. These obser-
vations could be explained by the phylogenetic trees of
the three types of influenza viruses, shown in Figs. 1, 2
and 3. Figure 1 shows that the HA1 protein sequences
can be clustered into two groups (approximately
corresponding to the two lineages, i.e. Victoria and Yama-
gata). The sequences of H1N1 are clearly divided by the
year 2009, as shown in Fig. 2. For H3N2 (Fig. 3), the HA1
sequences evolve serially along the direction of years (from
1968 to 2015). Because we calculate the mutations by
comparing two sequences from two adjacent years, it is
not surprising that the mutations of H3N2 are less than
H1N1 and B viruses. In addition, the high number of muta-
tions found in B viruses is probably due to the fact that we
did not discriminate the two lineages in this type of viruses.
Then we classified the flu-B HA1 sequences into two
lineages based on their distances from two standard
HA1 sequences of Victoria and Yamagata lineages. After
that, we applied our approach to the sequences of the
two lineages respectively. Results of rules are visualized
in Additional file 4: Figure S4 and Additional file 5:
Figure S5, for Yamagata and Victoria lineages respectively.
We can see that, after discriminating flu-B sequences into
two lineages, the numbers of mutations (within each
lineage) decrease significantly. Here we set the threshold
for support of rules to 1500 (versus 5000 before classifying
the lineages) and obtained 1110 and 69 rules for Yamagata
and Victoria lineages respectively. The results also suggest
that the Yamagata lineage may mutate more quickly than
the Victoria lineage.
Fig. 1 Phylogenetic tree of HA1 sequences of influenza B viruses. It’s indicated influenza virus B diverging into two lineages co-circulating around
the world, named as Yamagata lineage and Victoria lineage
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To compare the patterns of co-occurring site muta-
tions in A/H1N1 during and after the 2009 pandemic,
we applied our method to the H1N1 sequences from
2008 to 2011 (denoted as DATA_pdm), and from 2011
to 2014 (denoted as DATA_aft) respectively. Much more
mutations were obtained in DATA_pdm than DATA aft.
Therefore, we used different thresholds for the support
of the rules from the two datasets (5500 and 2000 for
DATA_pdm and DATA_aft respectively). The thresholds
for confidence are the same (i.e. 0.8). The rules for the
two datasets are visualized as networks shown in Fig. 4
(DATA_pdm) and Fig. 5 (DATA_aft). As seen, many muta-
tions happen in HA1 protein sequences of H1N1 during
the 2009 pandemic, and most of which are “driven” by the
seven site mutations: 128, 183, 186, 205, 216, 249 and 272.
For DATA_aft, in contrast, only several sites are co-
mutated frequently and they are highly inter-connected.
Interestingly, these highly inter-connected sites coincide
well with the mutations predicted by “nextflu” [35], as
shown in Fig. 6.
The analysis of co-occurring mutation patterns in A/
H3N2 is given in the section “Predictions of influenza
evolution” below.
Co-Mutation sites under strong selection pressure
We map the co-mutation sites predicted by our method on
the HA protein structures of influenza viruses. For H1N1,
we have two sets of co-mutations sites, i.e. “205, 216, 183,
249, 128, 186 and 272” from Fig. 4, and “69, 97, 143, 163,
197, 256, 260 and 283” from Fig. 5. The two sets of sites are
map to the HA protein structure of H1N1, as shown in
Figs. 7 and 8 respectively, where the red, blue, yellow, ma-
genta and green colors represent the five epitope regions,
the tan color denotes non-epitope region, and the co-
mutation sites are circled and marked with corresponding
numbers. We can observe that most of the co-mutation
sites fall into the epitope regions (see Table 2), indicating
that these mutated sites are probably under strong selection
pressure by human immune system. Similar observation has
been found in the case of H3N2, shown in Fig. 9. Table 3
shows the distribution of the detected sites in H3N2 on dif-
ferent epitope regions. The co-mutation sites in the HA1
protein of flu-B viruses are visualized in Fig. 10 (Yamagata
lineage) and Fig. 11 (Victoria lineage). There are four epi-
tope regions in flu-B viruses, highlighted by the red, blue,
cyan and green colors. The co-mutation sites are circled
with green lines and marked with corresponding numbers.
Fig. 2 Phylogenetic tree of HA1 sequences of A/H1N1 viruses. It’s clearly divided into two clusters before and after 2009, when the world swine
flu pandemic happened
The Author(s) BMC Medical Genomics 2016, 9(Suppl 3):69 Page 232 of 269
Fig. 3 Phylogenetic tree of HA1 sequences of A/H3N2 viruses. The tree was constructed using 1000 randomly selected sequences, which showed
an apparent selecting preference on the evolutionary path of A/H3N2
Fig. 4 The network representing the rules of co-mutation sites in H1N1 based on sequences from 2008 to 2011
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Fig. 5 The network representing the rules of co-mutation sites in H1N1 based on sequences from 2011 to 2014
Fig. 6 Site mutations predicted by “nextflu” [35]. The red rectangles are used to highlight the overlap with our prediction (Fig. 5)
The Author(s) BMC Medical Genomics 2016, 9(Suppl 3):69 Page 234 of 269
Fig. 7 Mapping co-mutation sites on HA1 protein of H1N1 (PDB ID: 4EDB [40]). The red, blue, yellow, magenta and green colors represent the five
epitope regions, the tan color denotes non-epitope region, and the co-mutation sites are circled and marked with corresponding numbers (similarly
for the following two figures, i.e. Figs. 8 and 9)
Fig. 8 Mapping co-mutation sites on HA1 protein of H1N1 (PDB ID: 4EDB [40])
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Predictions of influenza evolution
We predict the potential drifts with specific site mutations
in HA1 protein of influenza virus A/H3N2 based on our
rules (see Methods). To validate our method, we compare
the predictive results from our rules with the “observed”
mutations in different years (obtained from [26]). The com-
parison results are shown in Table 4. As seen, our method
can predict the drifts with specific mutations reasonably
well, especially for some years such as 1973 and 2004.
We also compare our results with those in [29], using
the same dataset as [29] (i.e. the sequences of H3N2 from
1968 to 2002). The rules of co-mutation sites are plot as a
network shown in Additional file 6: Figure S6. The follow-
ing site mutations are predicted both by our method and
Xia’s method (i.e. [29]): 50, 155 and 156. The mutation in
site 144 is only predicted by our method. Since the
“benchmark” for site mutations may not be unique, we
introduce another set of “observed” mutations generated
by BII-FluSurver [36]. We submitted all HA1 sequences of
H3N2 in 2003 to BII-FluSurver (using default parameters)
and counted the frequencies of all site mutations returned
by BII-FluSurver. Totally 4543 site mutations (with dupli-
cates) were obtained. The comparison of occurrence of
predicted mutations in the BII-FluSurver results is shown
in Additional file 7: Table S1, which shows that the over-
lap between our prediction and the BII-FluSurver re-
sults is similar to that of Xia’s prediction.
Discussion and Conclusion
In this paper, we propose a method based on association
rule mining to identify the co-occurring site mutations
for human influenza A(H3N2), A(H1N1) and B Viruses.
The rules of co-mutation sites characterize the antigenic
evolution of influenza viruses. We show that the co-
mutation sites in HA1 are all in the epitope regions,
indicting strong selection pressure by human immune
system in those sites. Furthermore, the rules obtained by
our method can be used to predict potential mutations
of influenza viruses in the future.
There are several directions to improve our study in
this paper. First, we could increase the number of sam-
pling process (i.e. N in Methods section) to increase
the statistic power of association rule mining. Second,
instead of randomly sampling two sequences from two
adjacent years, we can select two sequences with closer
Table 2 Sites detected co-mutated frequently with other sites
Dataset Detected sites Number of residues
at antigenic sites/Total
number of sites
A/H3N2 50, 53, 62, 137, 144, 145, 155, 156,




128, 183, 186, 205, 216, 249, 272 5/7
A/H1N1 (aft) 69, 97, 143, 163, 197, 256, 260,
283
4/8
B/Yamagata 48, 56, 75, 116, 182, 183, 266 1/7
B/Victoria 75, 88, 175, 199, 330, 235 1/6
Fig. 9 Mapping co-mutation sites on HA1 protein of H3N2 (PDB ID: 2YPG [41]). All sites are distributed on the five epitope regions, colored as
red, blue, green, yellow and magenta for epitope regions A, B, C, D and E respectively
The Author(s) BMC Medical Genomics 2016, 9(Suppl 3):69 Page 236 of 269
phylogenetic distance to calculate the mutations. Of course,
experimental data where phylogenetic relationships of
sequences are known would bring better results. In
addition, different weights could be assigned to differ-
ent years during sampling, e.g. to do more samplings
on the years with more sequences. Finally, aside from
analyzing the co-occurring mutations in HA protein,
we can also explore the co-evolving mutations patterns
in other proteins, where mutations may compensate for
each other. For example, HA and NA proteins of influ-
enza viruses are responsible for the viral’s binding and
cleavage from host cells. It would be very interesting to
detect the co-occurring mutations in these two pro-
teins, which are under selection pressure, to study their
cooperative manner at the genetic level.
Methods
Data
All HA protein sequences of human Influenza A/H3N2,
A/H1N1 and B Viruses were retrieved from the Influenza
Virus Resource at NCBI [34] up to October 8, 2015. The
sequences were searched from the year 1918 to the year
2015. We excluded the records without the information of
year and the sequences which are shorter than the full
length of HA1 (327, 312 and 345 residues for H1N1,
H3N2 and B viruses, respectively).
Because there is no record in some years for a particular
type of virus, we used the sequences from 1976 to 2015 for
H1N1, from 1968 to 2015 for H3N2, and from 1975 to 2015
for flu-B virus, to ensure the continuity. Totally 18,450 se-
quences were obtained after cleaning for H1N1, 18,019 se-
quences for H3N2, and 6538 sequences for flu-B virus. Then
we aligned these sequences using MEGA6 [37] and extracted
the HA1 sequences for the three types of viruses respectively.
Rule mining
After obtaining the HA1 sequences, we divided the se-
quences into different bins according to the year infor-
mation. Then a technique of sampling with replacement
was applied to randomly select one sequence from each
bin (i.e. year). We repeated the sampling process for N
times to obtain enough statistics. After that, the se-
quences from every two adjacent years were aligned to
obtain mutations between the two sequences. The re-
cords of site mutations were treated as “transactions” in
association rule mining [31], which was applied to find
the rules of co-occurring site mutations. Here LCM [38]
was used to carried out association rule mining.
Table 3 Distribution of detected sites on epitope regions
Epitope A Epitope B Epitope C Epitope D Epitope E
137 155 50 244 62
144 156 53 260
145 158 275
189
Fig. 10 Mapping co-mutation sites detected onto HA1 protein of flu B/Yamagata (PDB ID: 4NRJ [42]). The red, blue, cyan and green colors represent
120-loop, 150-loop, 160-loop and 190-helix respectively. The four clusters have been found to cause antigenicity variation, together forming a single
large antigenic site with overlapping epitopes. The co-mutation sites are circled and marked with corresponding numbers
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Mutation prediction
From the rules obtained from association rule mining, we
infer which sites tend to be co-mutated during the evolu-
tion of the influenza virus. To predict potential mutations
in the future, following [29], we first find out the sites
under positive selection and obtain the sites co-evolving
with the positive-selection sites, which would be predicted
as the sites to be mutated. In [29], the positive selection
site is defined as “a site that has been mutated between
successive years and then remains fixed in the population
for at least 1 year”. To obtain the sites under positive se-
lection, we need to determine which sites are mutated in a
particular year. Unfortunately, currently there is no stand-
ard way to obtain the yearly site mutations (i.e. the bench-
mark of our prediction), which make it difficult to
determine the positive selection sites. Therefore, here we
treat the sites occurring frequently in our rules (i.e. the
sites co-mutated frequently with other sites, or with large
in-degree) as the sites to be mutated.
Visualization
Phylogenetic trees were constructed with 1000 randomly
selected sequences from corresponding dataset men-
tioned above, using NCBI tools in “Influenza Virus
Table 4 The prediction results (for H3N2 in different years)
Year Mutations
1973 V78G V242I D275G N188D T122N G144D T155Y R207K L3F
✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔
1976 F3L D73N T83K T126N I217V I278S Q189K S145N
✔ ✔ ✔ ✔ ✔
1978 N53D D193N G158E K50R S137Y M260I D2N V244L G146S I62K
✔ ✔
2001 I226V D133N D124S T121N Y137S R57Q T192I D172E K62E V196A K156Q
✔ ✔ ✔ ✔ ✔ ✔ ✔
2004 V144N A131T E83K R50G W222R V202I G225D H155T H75Q Q156H
✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔
It’s for validation of our method, where ✔ means the site mutation is predicted successfully
Fig. 11 Mapping co-mutation sites detected onto HA1 protein of flu B/Victoria (PDB ID: 4NRJ [42]). The red, blue, cyan and green colors represent
120-loop, 150-loop, 160-loop and 190-helix respectively. The four clusters have been found to cause antigenicity variation, together forming a
single large antigenic site with overlapping epitopes. The co-mutation sites are circled and marked with corresponding numbers
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Sequence Tree” [34] based on the neighbor-joining
method and mPAM distance. Co-evolved sites output by
our method were mapped to the virus HA protein struc-
ture retrieved from the Protein Data Bank [39–42] using
Chimera (v1.11) [43]. The epitope regions of H1N1 and
H3N2 are marked according to [44–47]. The epitope in-
formation of flu-B are from [48, 49].
Additional files
Additional file 1: Figure S1. Visualization of rules for B virus (based on
all HA1 sequences of flu-B from 1975 to 2015). The numbers inside the
nodes denote the sites (numbering in the HA1 sequence), and the edges
represent the association of the site mutations. The same applies to the
rest figures of “Visualization of rules”. (PDF 673 kb)
Additional file 2: Figure S2. Visualization of rules for A/H1N1 virus
(based on all HA1 sequences of H1N1 from 1976 to 2015). (PDF 511 kb)
Additional file 3: Figure S3. Visualization of rules for A/H3N2 virus
(based on all HA1 sequences of H3N2 from 1968 to 2015). (PDF 286 kb)
Additional file 4: Figure S4. The network representing the rules of
co-mutation sites in B viruses (Yamagata lineage). (PDF 314 kb)
Additional file 5: Figure S5. The network representing the rules of
co-mutation sites in B viruses (Victoria lineage). (PDF 230 kb)
Additional file 6: Figure S6. Network of co-mutation sites based on H3N2
sequences from 1968 to 2002 (same dataset as in Xia et al.). (PDF 511 kb)
Additional file 7: Table S1. Comparison of site mutations prediction
(for H3N2 in the year 2003). (PDF 224 kb)
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